Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium

• Published in: Malaria Journal
• Main Authors: Kreeftmeijer-Vegter Annemarie R, van Genderen Perry J, Visser Leo G, Bierman Wouter FW, Clerinx Jan, van Veldhuizen Cees KW, de Vries Peter J
• Format: Article in Journal/Newspaper
• Language: English
• Published: BMC 2012
• Subjects: Intravenous artesunate; Severe malaria; Parasite clearance; Named patient program; European traveller; Arctic medicine. Tropical medicine; RC955-962; Infectious and parasitic diseases; RC109-216; Arctic; Traveller
• Online Access: https://doi.org/10.1186/1475-2875-11-102; https://doaj.org/article/778ba945cac44674aff4bbc7df4dd3ac

Abstract Background Intravenous (IV) artesunate is the treatment of choice for severe malaria. In Europe, however, no GMP-manufactured product is available and treatment data in European travellers are scarce. Fortunately, artesunate became available in the Netherlands and Belgium through a named pa...